Clinical Trial Detail

NCT ID NCT04171141
Title Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications

colorectal adenocarcinoma

esophagus adenocarcinoma

gastric adenocarcinoma

Therapies

PF-07062119

PF-07062119 + unspecified PD-1 antibody

PF-07062119 + unspecified VEGF antibody

Age Groups: senior adult

No variant requirements are available.